Recombinant human epo treatment: Beneficial in chronic kidney disease, chronic heart failure, or both? Editorial to: "Correction of anemia with erythropoietin in chronic kidney disease (stage 3 or 4): Effects on cardiac performance by Pappas et al."

Belonje, A. M. S., De Boer, R. A., & Voors, A. A. (2008, February). Recombinant human epo treatment: Beneficial in chronic kidney disease, chronic heart failure, or both? Editorial to: “Correction of anemia with erythropoietin in chronic kidney disease (stage 3 or 4): Effects on cardiac performance by Pappas et al.” Cardiovascular Drugs and Therapy. https://doi.org/10.1007/s10557-008-6079-x